The company attributes the better numbers to higher sales of both its own proprietary products as well as those that it distributes.
Hyphens Pharma International has reported 2HFY2021 earnings of $2.5 million, up 34.6% over the same six months to December period last year. Revenue was up 2.5% y-o-y to $62.1 million.
For the whole of FY2021, earnings increased by 11.1% to $6.8 million, on the back of a 4.1% increase in revenue to $125.9 million.
